These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 11055449)

  • 1. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Hunkeler EM; Hu T; Selby JV
    Health Serv Res; 2000 Oct; 35(4):791-812. PubMed ID: 11055449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization and cost impact of integrating substance abuse treatment and primary care.
    Parthasarathy S; Mertens J; Moore C; Weisner C
    Med Care; 2003 Mar; 41(3):357-67. PubMed ID: 12618639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis.
    Parthasarathy S; Weisner C; Hu TW; Moore C
    J Stud Alcohol; 2001 Jan; 62(1):89-97. PubMed ID: 11271969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's programs versus mixed-gender day treatment: results from a randomized study.
    Kaskutas LA; Zhang L; French MT; Witbrodt J
    Addiction; 2005 Jan; 100(1):60-9. PubMed ID: 15598193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Southern California Kaiser-Permanente Chemical Dependency Recovery Program evaluation: results of a treatment outcome study in an HMO setting.
    Ershoff D; Radcliffe A; Gregory M
    J Addict Dis; 1996; 15(3):1-25. PubMed ID: 8842847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment goals, continuity of care, and outcome in a day hospital substance abuse rehabilitation program.
    McKay JR; Alterman AI; McLellan AT; Snider EC
    Am J Psychiatry; 1994 Feb; 151(2):254-9. PubMed ID: 8296899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and costs of day hospital treatment and nonmedical day treatment for chemical dependency.
    Kaskutas LA; Witbrodt J; French MT
    J Stud Alcohol; 2004 May; 65(3):371-82. PubMed ID: 15222594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization and costs of substance abuse services within The HMO Group.
    Levin BL
    HMO Pract; 1993 Mar; 7(1):28-34. PubMed ID: 10171407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of public sector substance abuse treatment: comparison of a managed care approach to a traditional public sector system.
    Beattie MC; Hu TW; Li R; Bond JC
    J Behav Health Serv Res; 2005; 32(4):409-29. PubMed ID: 16215450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse day treatment and managed health care.
    Schneider RJ; Herbert M
    J Ment Health Adm; 1992; 19(1):119-24. PubMed ID: 10171034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between use of psychiatric services and five-year alcohol and drug treatment outcomes.
    Ray GT; Weisner CM; Mertens JR
    Psychiatr Serv; 2005 Feb; 56(2):164-71. PubMed ID: 15703343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.
    Satre DD; Mertens JR; Areán PA; Weisner C
    Addiction; 2004 Oct; 99(10):1286-97. PubMed ID: 15369567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes.
    Humphreys K; Moos RH
    Alcohol Clin Exp Res; 2007 Jan; 31(1):64-8. PubMed ID: 17207103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation.
    Alterman AI; O'Brien CP; McLellan AT; August DS; Snider EC; Droba M; Cornish JW; Hall CP; Raphaelson AH; Schrade FX
    J Nerv Ment Dis; 1994 Mar; 182(3):157-63. PubMed ID: 8113776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.